S. 4535 · 117th Congress
FDASRA Act of 2022
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 117th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
R
BurrSponsorNo cosponsors.
Food and Drug Administration Simple Reauthorization Act of 2022 or the FDASRA Act of 2022
What it does: CRS summary · Introduced in Senate · Jul 14, 2022
Food and Drug Administration Simple Reauthorization Act of 2022 or the FDASRA Act of 2022
This bill reauthorizes the authority of the Food and Drug Administration to collect certain fees related to drugs, medical devices, and biosimilar biological products and modifies such fees, including the base fee amounts.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: FDASRA Act of 2022
Also known as: Food and Drug Administration Simple Reauthorization Act of 2022
Latest action (Jul 14, 2022): Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Policy area: Health · Origin: Senate · Introduced: Jul 14, 2022
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.